|
miRNA | Change in expression | Target | Function | Reference |
|
let-7e | Upregulated in CD4+ cells, in EAE animals | IL-10 | Promotion of Th1/Th17 differentiation | [41] |
miR-15b | Downregulated in CD4+ cells, in MS patients and EAE animals | OGT | Inhibition of Th17 differentiation | [48] |
miR-20b | Downregulated in blood cells of MS patient and in EAE animals | RORγt, STAT3 | Inhibition of Th17 proliferation | [49] |
miR-21 | Upregulated in Th17 cells | SMAD7 | Promotion of Th17 differentiation | [63] |
miR-26a | Downregulated in peripheral blood lymphocytes of MS patients | IL-6 | Regulation of Th17/Treg balance | [50] |
miR-30a | Downregulated during Th17 differentiation in MS patient and EAE animals | IL-21R | Inhibition of Th17 proliferation | [65] |
miR-141 miR-200a | Upregulated in MS patients | FOXO3, GATA3, SMAD2 | Regulating Th17 and Treg differentiation | [43] |
miR-142 | Upregulated in MS patients and EAE animals | TGF-β SOCS1 ADCY9 | Promotion of Th17 differentiation and inhibition of Treg function | [54, 55] |
miR-145 | Downregulated in Treg cell, upregulated in blood cells of MS patients | FOXP3 SMAD3 | Inhibition of Treg proliferation | [44, 56] |
miR-146a | Upregulated in lesions in EAE animals | TRAF6 IRAK1 PRKCε | Inhibition of Th1 proliferation, supporting regulatory mechanisms | [66, 67, 69] |
miR-155 | Upregulated in MS patients | ETS1 DNAJA2 DNAJB1 | Promotion of Th17 differentiation | [59, 62] |
miR-183C | Upregulated in pathogenic Th17 cells | FOXO1 | Stimulation the production of pathogenic cytokines | [52] |
miR-301a | Upregulated in CNS-infiltrating T cells in EAE animals | PIAS3 | Promoting Th17 differentiation | [53] |
miR-326 | Upregulated in EAE animals | ETS1 | Promoting Th17 differentiation | [47] |
|